Risk-stratified assessment of 180-day mortality in severe alcoholic hepatitis

doi:10.3748/wjg.118301

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 30

This Article

(17)

(15)

(0)

(299)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Aug 14, 2026; 32(30): 118301
Published online Aug 14, 2026. doi: 10.3748/wjg.118301

Table 2 Comparison of baseline characteristics between the training and test sets

Variable	Training set (n = 1076)	Test set (n = 460)	P value
MDF	51.00 (40.00-67.25)	51.00 (40.00-69.00)	0.736
MELD	16.00 (13.00-20.00)	15.00 (13.00-19.00)	0.357
Gender (male)	1048 (97.4)	447 (97.2)	0.863
Age (years)	48.00 (42.00-54.00)	49.00 (43.00-55.00)	0.093
ALB (g/L)	26.00 (22.00-29.00)	26.00 (22.00-29.00)	0.313
GLO (g/L)	29.00 (23.00-35.00)	29.00 (23.00-36.00)	0.464
ALT (U/L)	30.00 (21.00-45.25)	31.00 (21.00-49.00)	0.288
AST (U/L)	69.00 (46.00-110.00)	69.00 (47.00-113.25)	0.664
ALP (U/L)	137.00 (103.00-185.00)	135.00 (104.00-176.25)	0.726
GGT (U/L)	69.00 (31.00-168.00)	74.50 (35.00-159.50)	0.254
TBA (μmol/L)	131.00 (69.00-197.00)	130.50 (74.07-201.75)	0.417
PTS (second)	20.00 (18.00-23.00)	20.00 (18.00-23.00)	0.484
PTA (%)	36.95 (31.08-42.30)	37.10 (31.27-42.00)	0.631
TBIL (μmol/L)	165.05 (97.10-305.95)	166.10 (97.08-293.00)	0.863
INR	1.73 (1.60-1.99)	1.76 (1.60-2.00)	0.404
CRE (μmol/L)	83.00 (67.00-116.00)	83.00 (68.00-107.00)	0.434
TG (mmol/L)	0.88 (0.60-1.37)	0.94 (0.63-1.37)	0.349
CHE (U/L)	2054.00 (1492.75-2703.00)	2080.50 (1524.50-2734.25)	0.343
CK (U/L)	69.00 (40.00-119.00)	65.00 (38.00-115.25)	0.298
FE (μmol/L)	19.55 (13.20-26.00)	20.25 (14.57-26.70)	0.133
AFP (ng/mL)	4.54 (2.75-8.02)	4.53 (2.81-8.00)	0.871
HGB (g/L)	96.00 (79.00-113.00)	99.00 (80.00-113.00)	0.503
PLT (× 10⁹/L)	71.20 (46.00-113.00)	71.00 (47.00-112.25)	0.875
SBP (yes)	323 (30.0)	150 (32.6)	0.334
Pulmonary infection (yes)	195 (18.1)	66 (14.3)	0.075
HRS (yes)	82 (7.6)	26 (5.7)	0.191
HE (yes)	263 (24.4)	110 (23.9)	0.846
Gastrointestinal bleeding (yes)	126 (11.7)	48 (10.4)	0.538
Glucocorticoid (yes)	73 (6.7)	24 (5.0)	0.247

Continuous variables are expressed as median (interquartile range) and categorical variables as n (%). MDF: Maddrey discriminant function; MELD: Model for end-stage liver disease; ALB: Albumin; GLO: Globulin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase; GGT: Gamma-glutamyl transferase; TBA: Total bile acid; PTS: Prothrombin time seconds; PTA: Prothrombin activity; TBIL: Total bilirubin; INR: International normalized ratio; CRE: Creatinine; TG: Triglyceride; CHE: Cholinesterase; CK: Creatine kinase; FE: Iron; AFP: Alpha-fetoprotein; HGB: Hemoglobin; PLT: Platelet Count; SBP: Spontaneous bacterial peritonitis; HRS: Hepatorenal syndrome; HE: Hepatic encephalopathy.

Full Size Table

Citation: Xv YW, Ling J, Hao XG, Xu TJ, Tian H, Lv S, You SL, Zhu B. Risk-stratified assessment of 180-day mortality in severe alcoholic hepatitis. World J Gastroenterol 2026; 32(30): 118301
URL: https://www.wjgnet.com/1007-9327/full/v32/i30/118301.htm
DOI: https://dx.doi.org/10.3748/wjg.118301

Xv YW, Ling J, Hao XG, Xu TJ, Tian H, Lv S, You SL, Zhu B. Risk-stratified assessment of 180-day mortality in severe alcoholic hepatitis. World J Gastroenterol 2026; 32(30): 118301 [DOI: 10.3748/wjg.118301]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.